AZD6738 & Gemcitabine as Combination Therapy
Condition(s):CancerLast Updated:June 4, 2021Recruiting
Hide Studies Not Open or Pending
Condition(s):CancerLast Updated:June 4, 2021Recruiting
Condition(s):Stage IA Pancreatic Adenocarcinoma; Stage IB Pancreatic Adenocarcinoma; Stage IIA Pancreatic Adenocarcinoma; Stage IIB Pancreatic AdenocarcinomaLast Updated:February 5, 2019Completed
Condition(s):Pancreatic Cancer, MetastaticLast Updated:June 26, 2013Withdrawn
Condition(s):Pancreatic Cancer; Metastatic Pancreatic CancerLast Updated:February 19, 2018Unknown status
Condition(s):Metastatic Pancreatic Ductal AdenocarcinomaLast Updated:November 8, 2023Recruiting
Condition(s):Resectable Pancreatic CarcinomaLast Updated:April 6, 2020Terminated
Condition(s):Invasive Bladder Cancer; Bladder CancerLast Updated:August 24, 2016Terminated
Condition(s):Small Cell Lung CancerLast Updated:January 17, 2014Unknown status
Condition(s):Bladder CancerLast Updated:October 26, 2023Active, not recruiting
Condition(s):Pancreatic CancerLast Updated:April 28, 2015Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.